COPD Stage 2 Prognosis

Chronic Obstructive Pulmonary Disease (COPD) Stage 2 Prognosis

COPD is a progressive disease that typically increases in severity over time. It is an irreversible disorder for which there is currently no cure. However, there are measures that one can take for a better quality of life. Although this is a dire prognosis, there are ways to combat the disease, and the first step is understanding the progression of COPD in order to understand COPD stage 2 prognosis.

The disorder starts in stage 1, with mild symptoms:

-Chronic coughing

-Sputum: coughing up mucus

-Dyspnea: breathing discomfort

-Shortness of breath

Stages of COPD

Stage 2 of COPD occurs when the symptoms listed above worsen due to the continued decline in lung function. In stage 2 of the disease, a patient will see their pulmonary function test results worsen. They will also notice the additional symptom of chest tightness. Long-acting bronchodilators are often introduced at this point to help alleviate this chest tightness. Long-acting bronchodilators don’t offer immediate relief, however, they do help a person breathe easier over a longer period of time.

Eventually stage 2 COPD will likely progress into stage 3. Stage 3 is when lung function further declines, causing the symptoms listed above to become even worse. Added symptoms at this stage include unintended weight loss and frequent respiratory infections. Additional treatment precautions might be added at this point, including daily medications and participation in a pulmonary rehabilitation class.

Smoking and COPD

According to one case study, scientists found that people with COPD had a much increased chance of mortality than those who do not. Using the GOLD System, researchers kept track for years of patients with COPD. The results found that current or ongoing smokers have a shorter life expectancy than patients that quit. In addition to quitting smoking, there are treatment options that a person with COPD can take to be proactive in slowing down the decline in lung function.

COPD Treatment Options

For those who have been diagnosed with COPD, the main goals of treatment are: symptom relief, slow down decline in lung function, improve daily lung function, decrease number of acute episodes (aka COPD exacerbations) and improvement in overall quality of life. Many COPD sufferers use supplemental oxygen along with daily medications to manage symptoms. For those with more developed stages of COPD, more serious measures like a lung transplant or reduction might be an option. There is, however, a minimally invasive, alternative treatment that helps most lung disease sufferers. Cellular therapy might help slow the development of lung disease and even improve it. Rather than managing symptoms like oxygen and medications, cellular therapy harnesses your body’s natural healing abilities, essentially healing the lung tissue. While cellular therapy is not a cure, it is an effective treatment that might provide lung disease sufferers with a much greater quality of life.

Of course, if you are looking for an alternative treatment for COPD, then the Lung Institute might be able to help! If you or someone you love would like know more about treatment options, feel free to contact one of our patient care coordinators today or call 888-745-6697 today.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.